Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Those quotes are at the bottom of every safe harbor act. The BODs of pink sheet stocks can do as the please, without worry of legal prosecution. It's typically best not to invest anything in stinky-pinks.
It appears that Lipocine will be added to the Russell Index.
Website: https://www.ftserussell.com
Website search link: https://www.ftserussell.com/search?text=Additions%202019&page=1
Article Tile: 2019 Preliminary Russell 3000 Index additions
Article file name: RMICRO_Additions_20190614.pdf
A few posters have asked where to find the post(s) with all of the Charles Vacarro and share/scam structure and shady business dealings, like being 10 other companies, prior to POTN, etc.
It might be a good idea to take those posts and either combine them into one post and make a sticky note out of them, or sticky note the few posts that explain everything, as to help protect people from deciding to invest in this corporate-welfare, self-enrichment, pink- sheet-penny-scam, dilution-factory, share-printing-scheme.
Thank you.
Well, obviously it was designed as a scam to begin with, otherwise they wouldn't have given Charles Vaccaro all those dillutive shares with no cost basis.
Get ready to be reverse split/dilluted out of all of you of your shares and investment capital.
As it runs out, Taurus and Billy were right all along.
Carry on now, to bankruptcy.
Lol @ Justinbailey, you are correct!
Hey, thanks for the correction, twice a day is better than three times per day, I hope it gets approved soon and I hope the once per day pill gets approved as well.
Also, let's keep in mind, that if Tlando approval happens, it's for the 3 times per day pill, that must be taken with meals. Apparently, the once per day pill is a ways away from submission/approval and it probably would not be submitted for approval if the 3 times per day gets rejected by the FDA.
Is anyone on this board worried about potentially having a little f competition from Lipocense's (LPCN) T-booster pill, Tlando? Which is up soon for a 3rd attempt at FDA approval?
I'm not sure what the stock price would be after Tlando FDA approval.
I agree with you, that a pill would be more appealing than an injection or a nasal spray.
However, a couple things that I'm keeping in mind is that the T-injection, Xyosted is quick, easy, painless and only a once a week injection...
Having to take a pill or several pills daily could be a hassle, especially if a high calorie meal is required, so maybe Tlando won't be as popular as thought?
I would personally take a pill over an injection any day.
There is a once daily T-booster, FDA approved nasal spray that never ended up having good sales, how ironic is that? I'd easily take a nasal spray if I needed.
What I'm getting at is, the FDA may not approve Tlando, citing the possibility for abuse, or they might claim a 2nd or 3rd end point was not meant, so they might keep moving the goal posts and society and the FDA is against masculinity in general.
Having said that, Tlando should have the best chance ever of getting approved and if approval fails this 3rd time around, I'd say that Tlando will never get approved.
Several years ago, biotech stocks were a good market sector, but I'm afraid that biotech/pharma stocks are not what they once were, because the government is talking about price regulation, so the days of pharma stock prices doubling or tripling, after FDA approval are gone, it's the increased sale and profits that move the pharm stocks up now.
Also, since there was a stock hype increase during the 1st and 2nd Tlando go rounds with the FDA, I think the stock increase hype drained out for this 3rd attempt.
My point is, I don't think the stock price will go up at all after Tlando FDA approval at least not until Tladno has been selling for one or two years, which may also require a partnership.
Obviously, if LPCN is bought out, after Tlando FDA approval, that would be the fastest way to make a big profit on having owned LPCN stock, before the buy out.
If LPCN doesn't get bought out, the biggest, most traditional way, but also the most time consuming way to profit is to hold it for years, as Tlando sales and profits increase, then sell LPCN.
Does anyone know anything about OVIT's shell and a reverse merger?
I agree with your pessimistic view, because that is the reality of the situation. Obviously there will be an r/s and more dilution. The main point here is, stay away from pink sheet penny stock scams and probably the entire OTC market.
Interesting that the bid is at .0001 and the ask is at .49.
With the massive and continued dilution, an r/s is basically the main way to get that dilution under control, which basically means instantly losing half your investment capital and half of your shares.
Well Gail, it seems as if you have provided more information and blown the lid off this entire scam...
Here's a likely scenario...
Apparently, there is a court case in August to resolve the C.V. shares and if that's true...
C.V. would probably want to dump all his shares, before the court case, so that he gets a maximum profit and if all his shares are sold before it goes to court, C.V. can't get screwed out of his money...
Even though, it's really C.V. who's screwing investors and POTN, the law would legally side with C.V., but he'd probably get more money, just be selling his shares on the open market, and...
If a reverse split is coming, C.V. would probably want to dump all his shares, before the r/s, so these are all bad things for us an POTN...
If C.V. didn't unload his shares before the court case and the judge ruled more favorably on POTNs side, with a realistic settlement and did not do an r/s, then that would be good for us and POTN.
Obviously I'm no genius here, so hopefully it makes sense and is an accurate assessment.
I will leave it up to the geniuses to decide or explain it better.
I can't imagine any company wanting to buy POTN, due to all of it's debt and scam-like share structure.
If the FDA were to rule in favor of CBD in edibles, then a bigger company would probably just put POTN out of business, by growing faster and better...
I understand what you're saying, that the owners of the .45 cent conversion rate would not want to allow an r/s, that is a logical opinion.
However, they don't own enough shares, to stop an r/s vote.
Obviously, we don't want an r/s and I don't think this is funny.
My point is, that pink sheet, penny stocks have a typical m.o., over-promise-hype, sucker people in, dilute like crazy, lie some more, dilute even more, more and more toxic debt, then a drastic and pre mature r/s and then a slow bankruptcy death and then, do it again.
Wash, rinse, repeat and do it again.
Good luck.
The toxic debt, the extreme dilution and the FDA uncertainty, seem to be the main problems here. As well as major competition and marketing costs. Many have stated that it's a pink sheet penny scam. We will most likely, soon, see a drastic reverse split. I'm doubting that this will ever be successful, even years from now. Welcome to the stinky pinks.
As it turns out, the negative posters in here were correct, POTN is a huge scam.
Toxic, insider debt
Massive dilution
Less sales this Q1, than the last Q1
FDA messing over CBD
Too much competition
With an uplist, usually comes a drastic and severe revers split
After the r/s continued dilution
Folks, the writing is on the wall here, those who invested in POTN will most likely lose every penny of their investment.
It's interesting that the ask is at 200.00, is it a mistake? Or a split or a merger or a reverse shell merger? I'm guessing it's a mistake.
I general, CNBC, MSNBC, CNN, CBS and ABC are fake news. Now, before you freak out and throw a tantrum and wet your panties...Realize, that I stated..."in general." Now go change, you are all wet!
Could this post be the truth? You decide! It's a repost from last year...
POTN - looked at this one a little bit tonight and POTN looks like one of the biggest insider enrichment schemes going right now. The Issuer has a super suspicious debt Note that looks like it is being used for all sorts of shady purposes.
The controversy is over a Note originally dated February 1, 2015 or June 2, 2014 (depending on which filing you are viewing) for $1,850,000 owed to somebody with the initials D.G.
Going back through the POTN filings we learn of a David Grey that owned debt in POTN starting way back in 2010.
On June 2, 2013, $33,120 of the debt owed to David Grey (D.G.) was converted into 138,000,000 free trading shares of stock at $.00024/share. Those 138,000,000 free trading shares of stock were split between David Grey and Robert Pike.
The financial report for the period ending December 31, 2014 showed David Grey (D.G.) being owed $51,591 as of December 31, 2013 but the balance being down to $0 by December 31, 2014.
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=132998
Yet according to the very next financial report for the period ending March 31, 2015, D.G. had an outstanding debt Note for $1,850,000 dated June 2, 2014 of which $1,395,161 was still owed.
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=137343
If D.G. was owed $1,850,000 from June 2, 2014 how come that Note was not mentioned in the financial report for the period ending December 31, 2014?
What changed starting at the beginning of 2015 is that the POTN shell got a new CEO/control person named Steven Buckner who appears to have been more than happy creating a $1,850,000 Note out of thin air, back dating it to June 2, 2014, and assigning the Note to somebody previously involved in the shell.
When the financial statement for the period ending June 30, 2015 hit the amount owed to D.G. was listed at $1,402,861 because of interest and we get a date of February 1, 2015 for the Note
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=144943
Umm wait??? Is it June 2, 2014 or February 1, 2015? Future filings will use the date June 2, 2014. It sure looks like the Note was back dated and in the June 30, 2015 financial statement they used the actual date of the bogus Note (forgetting to use the back dated date).
During the 3rd quarter of 2015 a small portion of the $1,402,861 Note (roughly $25,000) was converted into 370,000,000 shares of free trading stock ($.00006/share). According to the following POTN filing
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=147024
Midam Ventures LLC got 70,000,000 free training shares of stock and Micro Cap Equity Group got 300,000,000 free trading shares of stock leaving a balance owed to D.G. on the Note of $1,375,229 as of September 30, 2015
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=147023
Micro Cap Equity Group LLC is a Florida entity controlled by Ibrahim Almagarby. In November 2017, the SEC charged Almagarby and his company.
https://www.sec.gov/litigation/litreleases/2017/lr23992.htm
https://www.sec.gov/litigation/complaints/2017/comp23992.pdf
According to the SEC Complaint, between 2013 - 2016, Almagarby/Micro Cap Equity Group was engaging in the practice of acquiring old debt and converting it into free trading stock (participating in a penny stock offering) without being registered as a broker/dealer. All total, the SEC said that Almagarby bought aged debt in 39 different Issuers selling more than 7.4 billion shares into the market reaping gains of $1,474,901,63.
Midam Ventures LLC is also a Florida entity that is controlled by Adam Heimann (a close associate of Jason Spatafora aka Wolf of Weed Street). Midam Ventures LLC wasn’t singled out by the SEC like Micro Cap Equity Group LLC.
When the financial statement for the period ending September 30, 2015 hit the amount owed to D.G. was listed at $1,375,229 and the Note was dated at February 1, 2015.
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=147023
The financial statement for the period ending December 31, 2015 showed the Note as being reset back to $1,850,000 (ignoring the previous conversions) and back dated again to June 2, 2014 then another $120,449 in interest accumulated since June 2, 2014 was tacked on making the amount due on the Note $1,984,000. Instead of D.G. the Note was said to be owned by S.N.D.
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=157344
S.N.D. stands for Sign N Drive Auto Mall Inc.
As you can see at the following link, Sign N Drive Auto Mall Inc is controlled by Charles Vaccaro.
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=SIGNNDRIVEAUTOMALLINC%20L170002168351&aggregateId=flal-l17000216835-a4d96a9b-543e-4885-a5cc-f5b27d671c2b&searchTerm=Sign%20Gate%2C%20Llc&listNameOrder=SIGNGATELLC%20L170000689291
Charles Vaccaro was the old CEO of the POTN shell from 2012 until 2014 (back when David Grey was first converted debt into free trading stock). Vaccaro briefly left in 2014 but obviously re-emerged in February of 2015.
Prior to his involvement in the POTN shell, Charles Vaccaro had a shady past through his involvement in Team Trading (aka HLV Trading, Velez Capital Management, Team Trading LLC) - a company that left a lot of unhappy customers claiming that Vaccaro and his partners stole their money and ran
http://investimonials.com/prop-firms/reviews-team-trading.aspx?page=3
And before that Vaccaro was involved in some shady broker named Gold Country Securities aka F1 TRADING.COM, INC as its President and part owner
https://brokercheck.finra.org/individual/summary/2796589
https://brokercheck.finra.org/firm/summary/20375
https://files.brokercheck.finra.org/firm/firm_20375.pdf
Vaccaro was fined $30,000 and suspended because of some regulatory event and when his firm failed to pay the fine it was expelled by FINRA. More info at the following links:
http://www.siliconinvestor.com/readmsg.aspx?msgid=9592773
https://www.elitetrader.com/et/threads/team-trading-llc-team-trading-extreme-llc.188389/
Sign N Drive is also a trademark that POTN applied for after acquiring Sunrise Auto Mall Inc in February of 2015 from Steven Buckner making Steven Buckner the new CEO.
Steven Buckner incorporated Sunrise Auto Mall Inc on April 3, 2014, but on February 11, 2015 less than a week after the POTN shell acquired the entity making Buckner the new POTN CEO, Charles Vaccaro took over as the president of Sunrise Auto Mall Inc
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=SUNRISEAUTOMALL%20P140000302990&aggregateId=domp-p14000030299-eea41579-f6e3-440c-b74a-446d5cfad809&searchTerm=Sunrise%20Auto%20Mall&listNameOrder=SUNRISEAUTOMALL%20P140000302990
http://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2015%5C0219%5C69335873.Tif&documentNumber=P14000030299
It sure looks like that S.N.R. Note (formerly the David Grey "D.G" Note) is controlled by Charles Vaccaro, who is a POTN Company insider.
Just as disturbing is how all the prior conversions on the Note that took it down to $1,375,229 were ignored as if they never happened even though those conversions helped cause the stock to be diluted to 6,497,571,520 shares outstanding by September 30, 2015.
At the end of 2015, the same time the the Note was reset from $1,375,229 up to $1,984,000, attorney Gary L Blum took over as the CEO of the shell.
Gary L Blum even did the attorney letter for POTN at this time
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=153852
Gary L Blum did a large reverse split for the ticker In early 2016 but despite the much higher share price the subsequent Note conversions would still be made at a fraction of a penny.
The financial statement for the period ending March 31, 2016 showed a balance of $2,012,500 on The Note and the Note still being listed as an S.N.D. Note
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=157345
The financial statement for the period ending June 30, 2016 showed a balance of $1,941,000 on the Note
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=159394
According to the POTN filings (which has portions cut off), during the 2nd quarter of 2016:
$1,000 of the SND Note was converted into 1,000,000 free trading shares by Micro Cap Equity Group LLC ($.001/share)
$11,000 of the Note was converted into 2.750,000 free trading shares by Sign N Drive Auto Mall Inc ($.004/share)
$6,000 of the SND Note was converted into 1,500,000 free trading shares by Inet Cap Holdings ($.004/share)
$6000 of the SND Note was converted into 1,500,000 free trading shares by Beachwood Cap ($.004/share)
$6000 of the SND Note was converted into 1,500,000 free trading shares by SCA Capital Bty Ltd ($.004/share)
$50,400 of the SND Note was converted into 11,200,000 free trading shares by D.R,, P.U., ??, and K.R. ($.004/share)
$??? of the SND Note was converted into 1,555,555 free trading shares by W.T.
$38,000 of the SND Note was converted into 19,000,000 free trading shares by Rockwell Capital Partners ($.002/share)
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=159396
All total $124,400 was converted into 40,005,555 free trading shares of stock during the second quarter of 2016 but the Note balance only went down by $71,500. No way it could have accumulated that much interesting in 3 months.
Also interesting is that during the 2nd quarter of 2016 coinciding with all those stock sales, SND wired $79,000 back to POTN in the form of two new debt Notes both accumulating interest at 8%
And still more interesting is that POTN claimed to have a cash positive balance sheet of $738,424 for the year ending 2015. If they had an excess of $738,424 in cash why were they converting old debt into free trading stock at a fraction of the market price instead of paying off the debt with that excess cash? And why were they borrowing new money from the same suspicious lender with lopsided conversion terms if they had all that cash left over from their operations?
And another question is if they had a cash positive balance of $738,424 from business operations why did they only show $710 in cash on their balance sheet?
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=157344
So much just doesn’t add up.
Around this time POTN also changed its name briefly to SND Auto Group Inc
SND just like the new owner of the suspicious Note
The financial statement for the period ending September 30, 2016 showed a balance of $1.969,000 on the Note
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=161885
The financial statement for the period ending December 31, 2016 showed a balance of $2,033,283 on the Note and the owner was now listed as “Sign” still short for Sign n Drive Auto Mall Inc (Charles Vaccaro)
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=168249
Some time in 2016 Randall Goulding became the new legal counsel for POTN
Later in 2017, Randall’s brother, Richard Goulding took over as the new CEO for POTN with Gary L Blum moving into the role of Chairman.
It is unclear at what point, but around the same time the Goulding got involved the Note was given a set conversion rate of $.003/share.
The financial statement for the period ending March 31, 2017 showed the balance on the “Sign” Note at $1,956,186
https://www.otcmarkets.com/financialReportViewer?symbol=POTN&id=174826
Subsequent POTN filings give us all sorts of juicy details about new Note conversions.
During the first quarter of 2017 $117,000 of the Note was converted into 39,000,000 free trading shares of stock ($.003/share). It was during this time that POTN started to really get pumped for the first time as a higher tier type Cannabis stock and saw the price climb from around $.012/share to around $.05/share. “Sign” could have sold those 39,000,000 shares for over $800,000.
During the 3rd quarter of 2017 $246,000 of the Note was converted into 82,000,000 free trading shares of stock ($.003/share) during this time the stock traded between $.05 - $.10/share. “Sign” could have sold those 82,000,000 shares for over $5,000,000.
Also suspicious is the fact coinciding with “Sign” getting free trading stock and selling the stock into the market, “Sign” began loaning new money to POTN.
According to the POTN filings, during the second quarter of 2017, “Sign” wired $285,500 to POTN in the form of a new Note convertible into stock at $.003 with no interest. And during the third quarter of 2017, “Sign” wired $477,500 to POTN in the form of a new Note convertible into stock at $.003/share with no interest.
It appears that "Sign" was selling stock then using the proceeds to fund the POTN business operations.
Counting the new loans. “Sign” is now owed $2,418,624 by POTN as of September 30, 2017. At $.003/share that is 806,208,000 shares worth over $685,000,000 at the current $.85/share price.
In all honesty, it looks to me like me like the David Grey "D.G."/Sign N Drive Auto Mall Inc "S.N.D."/“Sign” Note is really a bogus back dated insider controlled Note and money being made through stock sales from the Note are being wired back to the company to fund the POTN operations and possibly even to create bogus revenues. It reminds me very much of what the SEC/DOJ said that Fusion Pharm Inc (FSPM) was doing
https://www.sec.gov/litigation/admin/2016/33-10210.pdf
POTN claims in its most recent financial statement to have a cash positive balance sheet of $663,234 during the first 9 months of 2017 so why if they made $663,234 after expenses are they converting old debts at such lopsided conversion rates and borrowing more money from that same lender at such lopsided conversion rates?
Something isn’t adding up.
With all the volume (almost $30 million in volume traded on 1/26/18 alone), POTN could attract scrutiny from the SEC. I'm not so sure they would be able to survive if the SEC starts looking under the hood.
Side Note:
The current CEO of POTN is Richard Goulding brother of Randall Goulding who has a very very shady history in penny stocks going back to his old The Nutmeg Group LLC days
https://www.sec.gov/litigation/complaints/2009/comp20972.pdf
Another Defendant in the SEC litigation against The Nutmeg Group LLC was David Goulding.
David Goulding has the initials D.G. just like the suspicious POTN Note holder “David Grey” which is a pretty interesting coincidence.
It's refreshing to have you aboard, BillyTBag!
I saw the volume yesterday, wasn't it like 6 figures worth of shares, bought and sold, or vise versa? Do you have L2 access? How can we find out the details? I just assumed it was another negative sigh of someone bailing out...Wish it was a sign that OVIT was going to have a new protocol and/or do a reverse shell merger.
To be or not to be, that is the question! Asking "why" is lame!
Mess124, absolutely not! Looking in the stock room at the box, would be to easy! It's probably not Diamond anyway :(
Lipocine is suing Clarus.
SALT LAKE CITY, April 3, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has filed suit against Clarus Therapeutics, Inc. ("Clarus") in the United States District Court ("Delaware") alleging that Clarus's JATENZO(R) product infringes six of Lipocine's U.S. patents: 9,034,858; 9,205,057; 9,480,690; 9,757,390; 6,569,463; and 6,923,988.
"We have invested significant resources in developing innovations that have led to our importantly held strong intellectual property rights. We will defend those rights when infringed upon," said Dr. Mahesh Patel, Chairman, President and Chief Executive Officer of Lipocine.
About Lipocine
Lipocine Inc. is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes four development programs: TLANDO, LPCN 1144, LPCN 1111 and LPCN 1107. TLANDO, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men. LPCN 1144, an oral product of bioidentical testosterone, recently completed a proof-of-concept clinical study demonstrating the potential utility in the treatment of NASH. LPCN 1111, a novel oral prodrug of testosterone, originated and is being developed by Lipocine as a next-generation oral testosterone product with potential for once-daily dosing and is currently in Phase 2 testing. LPCN 1107 is potentially the first oral hydroxyprogesterone caproate product candidate indicated for the prevention of recurrent preterm birth and has been granted orphan drug designation by the FDA. An End of Phase 2 meeting with the FDA has been completed. For more information, please visit www.lipocine.com
Forward-Looking Statements
This release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements that are not historical facts regarding Lipocine's product candidates and related clinical trials, the timing of completion of clinical trials, the potential uses and benefits of our product candidates, and our product development efforts. Investors are cautioned that all such forward-looking statements involve risks and uncertainties, including, without limitation, the risks that the FDA will not approve any of our products, risks related to our products, expected product benefits not being realized, clinical and regulatory expectations and plans not being realized, new regulatory developments and requirements, risks related to the FDA approval process including the receipt of regulatory approvals, the results and timing of clinical trials, patient acceptance of Lipocine's products, the manufacturing and commercialization of Lipocine's products, and other risks detailed in Lipocine's filings with the SEC, including, without limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Lipocine assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as required by law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lipocine-seeks-injunction-against-the-marketing-of-clarus-therapeutics-jatenzo-for-testosterone-replacement-therapy-300823892.html
SOURCE Lipocine Inc.
/CONTACT: Morgan Brown, Executive Vice President & Chief Financial Officer, Phone: (801) 994-7383, mb@lipocine.com, Investors: Hans Vitzthum, Phone: (617) 535-7743, hans@lifesciadvisors.com
/Web site: http://www.lipocine.com
> Dow Jones Newswires
April 03, 2019 09:34 ET (13:34 GMT)
Onward and upward.
Not to be paranoid, but I knew the FDA/government would step and and screw us over. Yes, I realize the government did us some good, regarding the Farm bill, but know it's time for us to get raked over the coals and screwed over.
Whenever something good happens, it's been my experience that the economy, a bad boss or the government steps in to ruin it.
Now, you can all experience the vast joys of failure, congratulations!
I'd consider myself lucky to escape with a break even, but I'd rather stay long for a big win!
Screw the FDA to hell!!!
Dead board, dead stock, dead ticker, dead company, dead, dead, dead!
As BillyTBone would say, Toxic debt, toxic debt, fair value .06.
Bate, keep in mind that the comment from Warren Buffet about "buying when there is blood in the streets" was not in regarding OTC penny stocks, it was regarding real companies on Nasdaq and Dow.
No Matter how gung ho you are about INNV, it's still a loosing company and even if Boyd took over and booted our Dr.D, the product line up, sucks.
The more money you put into INNV, the morr money you will lose.
Since INNV won't ever trade on the Nasdaq, it should trade on the NYSE.
That's true Bate and the really said thing about that idiot Syd is that he had an illusion of credibility, which helped sucker many people into investing and losing even more.
The truth is, Syd was a dumb idiot and lost himself and others lots of money.
Keep in mind, that even though you haven't sold, you've lost your investment value here, because...
The pps won't go up from here and at some point, before you pass away, you'll have to sell and even if you did not sell and your beneficiaries did not sell, eventually, they'll have to sell for a loss.
The r/s had nothing to do with uplisting to the Nasdaq.
Even if Innovus V.D. uplisted to the Nasdaq. Typically, Nasdaq investors are smarter than stinky pinky investors. Most Nasdaq investors won't invest in a non profitable company, especially once they look at the scheme and realize what we now know.
The pps is going down due to these reasons:
Drastic and premature r/s.
Extreme dilution of shares.
Investors selling.
Investors not buying.
Lies of profitability.
Lies of the Fruiticare ANDA.
25 million shares issued to Novalare for no reason.
Huge salaries and bonuses the BOD receives.
Sued for 5 million + court costs and the counter lawsuit costs.
Unusual product names.
Lackluster products.
Advertising scheme using the dying medium of newspapers.
Can you say "lifestyle company?"
Can you say bankruptcy?
Ok, the TLando blood pressure results should be released soon.
TLando is roughly 8 months away from FDA approval or rejection.
My take is that if a good result for the blood pressure study is announced, it won't boost the pps.
In my opinion a TLando FDA approval, won't boost the pps.
Here's what could boost the pps.
TLando sales, profitability and increased profitability.
Lipocine being bought out.
The days of any biotech's pps going higher on good news and FDA approval is largely gone.
However, my prediction is that:
An r/s and massive dilution will occur, to extend huge BOD salaries and bonuses and to stay in business, so say goodbye to your investment "value" and any potential profits.
Syd lost $240,000 and expects to lose all of $280,000 he had "invested."
Even Syd agrees with me now:
"I had an appointment with my portfolio manager at TDAmeritrade today. I was hesitant to face the music but I thought once I accept the loss/defeat here, things can be better managed. My current loss is around $240,000 and there is a good chance, I will lose the remaining $35-$40k worth of equity left in INNVD. Any loss can be tough but this was especially hard because of some unexplainable reason.
Please know that I always tried to share my comments with a positive spirit and I posted what I truly believed at the time based on the intel available. Clearly, and by all accounts, this equity turned-out to be a bad investment. Poor management by the CEO and too much dilution and now this 1:105 RS, just killed it.
Lastly, I appreciate all the feedback I got on this MB these past two years. Mostly, you were great but some criticism and the personal attacks were hard to take but I accept that as part of the process. Wish everyone the best and while I will listen to one more earnings call to see if there is any hope of going up but will not hold my breath. Hate to see these horrible results!
For what it is worth, steven, KM, Eric, Edward et al., I always appreciated your humor and opposing views. We must always value diversity of thought and dissent. You guys were right and I was wrong. God bless!"
Uh oh, POTN lost out to Curaleaf on CVS. Uh oh, POTN doesn't make any actual products. Uh, POTN is going out of business one way or another, soon, very soon.
The reason Dr.D did the r/s at .045, before the Q4 2018 report, is because Q4 2018 sucked and Dr.D knows it...
The Q4 2018 report would have even brought down the pps to, perhaps -.045.
The highest Dr.D could get the pps to before the r/s was .045.
If you thought this 1st r/s sucked, then just wait for...
The Q4 2018 report and if you think that was bad, then just wait for the...
2nd r/s and if you think that was bad, then just wait for...
More dilution and if you think that was bad, just wait for...
The pps to drop back down to .045 and if you think that was bad, just wait for...
Bankruptcy to be filed...
Wow GI, you really are correct, that it's dropping like a rock. It's already down and additional dollar per day today.
Like you said, tomorrow it will be down and additional buck, soon back down to .045 and bankruptcy.
Exactly Bate, I am totally wiped out! I would be lucky to live in a van down by the river.
Why aren't the tards posting about "Perfect PURA" anymore?